Author

Linda Zhang

Baylor College of Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Ashley BoiceiD· 1 shared Brunie H. Felding· 1 shared Carlos Bueso-RamosiD· 1 shared Chiraag Deepak KapadiaiD· 1 shared Chong ZhaoiD· 1 shared Courtney Denton DinardoiD· 1 shared Curtis E. GumbsiD· 1 shared Daisuke NakadaiD· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Ashley BoiceORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

H2AX C-Terminal Dipeptide Truncation: A Master Switch of the DNA Damage Response.

Faith M Joseph, Matthew V. Holt, John Michael Jerome, Linda Zhang, Ashley Boice, Patricia D. Castro, Sofía I. Aramburu, Ruhee Dere, Susan M. Rosenberg, David R. Rowley, Nicolas L. Young

This paper identifies KDM4A-mediated H2AX truncation as a mechanism that suppresses DNA damage response signaling by preventing γH2AX formation.

bioRxiv · May 11, 2026 · PreprintMolecular Biology

Clonal evolution of hematopoietic stem cells after cancer chemotherapy

Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno, Chiraag Deepak Kapadia, Ken Furudate, Jyoti Nangalia, Michael Spencer Chapman, Linda Zhang, Jennifer Padilla, Li Zhao, Joanne I. Hsu, Chong Zhao, Shujuan Chen, Tomoyuki N. Tanaka, Zongrui Li, , Koichi Takahashi

This study examines how chemotherapy affects clonal diversity and mutation patterns in hematopoietic stem cells, finding that melphalan increases mutational burden and promotes clonal aging, potentially leading to therapy-related myeloid neoplasms.

Nature Genetics · Jul 1, 2025Peer-reviewedCancer Biology

Single-step Enzymatic Glycoengineering for the Construction of Antibody-cell Conjugates

Jie Li, Mingkuan Chen, Zilei Liu, Linda Zhang, Brunie H. Felding, Gregoire Lauvau, Michael Abadier, Klaus Ley, Peng Wu

This paper describes an enzymatic method to modify live cells with antibodies, creating antibody-cell conjugates that show enhanced tumor targeting and activity.

bioRxiv · Mar 10, 2018 · PreprintBioengineering